Literature DB >> 30530607

Role of the Hydrophobic Bridge in the Carbapenemase Activity of Class D β-Lactamases.

Nichole K Stewart1, Clyde A Smith2, Nuno T Antunes1, Marta Toth1, Sergei B Vakulenko3.   

Abstract

Class D carbapenemases are enzymes of the utmost clinical importance due to their ability to confer resistance to the last-resort carbapenem antibiotics. We investigated the role of the conserved hydrophobic bridge in the carbapenemase activity of OXA-23, the major carbapenemase of the important pathogen Acinetobacter baumannii We show that substitution of the bridge residue Phe110 affects resistance to meropenem and doripenem and has little effect on MICs of imipenem. The opposite effect was observed upon substitution of the other bridge residue Met221. Complete disruption of the bridge by the F110A/M221A substitution resulted in a significant loss of affinity for doripenem and meropenem and to a lesser extent for imipenem, which is reflected in the reduced MICs of these antibiotics. In the wild-type OXA-23, the pyrrolidine ring of the meropenem tail forms a hydrophobic interaction with Phe110 of the bridge. Similar interactions would ensue with ring-containing doripenem but not with imipenem, which lacks this ring. Our structural studies showed that this interaction with the meropenem tail is missing in the F110A/M221A mutant. These data explain why disruption of the interaction between the enzyme and the carbapenem substrate impacts the affinity and MICs of meropenem and doripenem to a larger degree than those of imipenem. Our structures also show that the bridge directs the acylated carbapenem into a specific tautomeric conformation. However, it is not this conformation but rather the stabilizing interaction between the tail of the antibiotic and the hydrophobic bridge that contributes to the carbapenemase activity of class D β-lactamases.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  antibiotic resistance; mechanisms of resistance; β-lactamases

Mesh:

Substances:

Year:  2019        PMID: 30530607      PMCID: PMC6355612          DOI: 10.1128/AAC.02191-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

Review 2.  Structure-Function Relationships of Class D Carbapenemases.

Authors:  Jean-Denis Docquier; Stefano Mangani
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

3.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

Review 4.  Clinical relevance of the ESKAPE pathogens.

Authors:  Jack N Pendleton; Sean P Gorman; Brendan F Gilmore
Journal:  Expert Rev Anti Infect Ther       Date:  2013-03       Impact factor: 5.091

5.  Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis.

Authors:  Elena Santillana; Alejandro Beceiro; Germán Bou; Antonio Romero
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-20       Impact factor: 11.205

Review 6.  Class D β-lactamases: a reappraisal after five decades.

Authors:  David A Leonard; Robert A Bonomo; Rachel A Powers
Journal:  Acc Chem Res       Date:  2013-07-31       Impact factor: 22.384

7.  Design, synthesis, and crystal structures of 6-alkylidene-2'-substituted penicillanic acid sulfones as potent inhibitors of Acinetobacter baumannii OXA-24 carbapenemase.

Authors:  German Bou; Elena Santillana; Anjaneyulu Sheri; Alejandro Beceiro; Jared M Sampson; Matthew Kalp; Christopher R Bethel; Anne M Distler; Sarah M Drawz; Sundar Ram Reddy Pagadala; Focco van den Akker; Robert A Bonomo; Antonio Romero; John D Buynak
Journal:  J Am Chem Soc       Date:  2010-09-29       Impact factor: 15.419

8.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

9.  The 1.4 A crystal structure of the class D beta-lactamase OXA-1 complexed with doripenem.

Authors:  Kyle D Schneider; Mary E Karpen; Robert A Bonomo; David A Leonard; Rachel A Powers
Journal:  Biochemistry       Date:  2009-12-22       Impact factor: 3.162

Review 10.  OXA β-lactamases.

Authors:  Benjamin A Evans; Sebastian G B Amyes
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

View more
  14 in total

1.  The crystal structures of CDD-1, the intrinsic class D β-lactamase from the pathogenic Gram-positive bacterium Clostridioides difficile, and its complex with cefotaxime.

Authors:  Nichole K Stewart; Clyde A Smith; Marta Toth; Anastasiya Stasyuk; Sergei B Vakulenko
Journal:  J Struct Biol       Date:  2019-09-21       Impact factor: 2.867

2.  Structural Insights into the Mechanism of Carbapenemase Activity of the OXA-48 β-Lactamase.

Authors:  Clyde A Smith; Nichole K Stewart; Marta Toth; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

3.  Effects of Inactivation of d,d-Transpeptidases of Acinetobacter baumannii on Bacterial Growth and Susceptibility to β-Lactam Antibiotics.

Authors:  Marta Toth; Mijoon Lee; Nichole K Stewart; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2021-11-15       Impact factor: 5.938

4.  Identifying Oxacillinase-48 Carbapenemase Inhibitors Using DNA-Encoded Chemical Libraries.

Authors:  Doris Mia Taylor; Justin Anglin; Suhyeorn Park; Melek N Ucisik; John C Faver; Nicholas Simmons; Zhuang Jin; Murugesan Palaniappan; Pranavanand Nyshadham; Feng Li; James Campbell; Liya Hu; Banumathi Sankaran; B V Venkataram Prasad; Hongbing Huang; Martin M Matzuk; Timothy Palzkill
Journal:  ACS Infect Dis       Date:  2020-03-25       Impact factor: 5.084

5.  A surface loop modulates activity of the Bacillus class D β-lactamases.

Authors:  Nichole K Stewart; Monolekha Bhattacharya; Marta Toth; Clyde A Smith; Sergei B Vakulenko
Journal:  J Struct Biol       Date:  2020-06-05       Impact factor: 2.867

6.  Local Interactions with the Glu166 Base and the Conformation of an Active Site Loop Play Key Roles in Carbapenem Hydrolysis by the KPC-2 β-lactamase.

Authors:  Ian M Furey; Shrenik C Mehta; Banumathi Sankaran; Liya Hu; B V Venkataram Prasad; Timothy Palzkill
Journal:  J Biol Chem       Date:  2021-05-19       Impact factor: 5.157

7.  In Crystallo Time-Resolved Interaction of the Clostridioides difficile CDD-1 enzyme with Avibactam Provides New Insights into the Catalytic Mechanism of Class D β-lactamases.

Authors:  Nichole K Stewart; Marta Toth; Anastasiya Stasyuk; Sergei B Vakulenko; Clyde A Smith
Journal:  ACS Infect Dis       Date:  2021-04-28       Impact factor: 5.578

8.  C6 Hydroxymethyl-Substituted Carbapenem MA-1-206 Inhibits the Major Acinetobacter baumannii Carbapenemase OXA-23 by Impeding Deacylation.

Authors:  Nichole K Stewart; Marta Toth; Maha A Alqurafi; Weirui Chai; Thu Q Nguyen; Pojun Quan; Mijoon Lee; John D Buynak; Clyde A Smith; Sergei B Vakulenko
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

9.  Structural Analysis of The OXA-48 Carbapenemase Bound to A "Poor" Carbapenem Substrate, Doripenem.

Authors:  Krisztina M Papp-Wallace; Vijay Kumar; Elise T Zeiser; Scott A Becka; Focco van den Akker
Journal:  Antibiotics (Basel)       Date:  2019-09-11

10.  Mechanistic Insights into β-Lactamase-Catalysed Carbapenem Degradation Through Product Characterisation.

Authors:  Christopher T Lohans; Emily I Freeman; Emma van Groesen; Catherine L Tooke; Philip Hinchliffe; James Spencer; Jürgen Brem; Christopher J Schofield
Journal:  Sci Rep       Date:  2019-09-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.